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Case Report
A 58-year-old woman with a history of hyperlipidemia and 
drug-refractory paroxysmal atrial fibrillation was referred to our 
electrophysiology practice for catheter ablation. Her preoperative 
medications only included digoxin and aspirin, and these were not 
withheld prior to the procedure. A preoperative transesophageal 
echocardiogram confirmed the absence of thrombus in the left 
atrial appendage. Transseptal catheterization of the left atrium 
was performed with the aid of intracardiac echocardiography 
(AcuNav, Siemens Medical Solutions, Inc., Mountain View, CA) 
by direct puncture of the mid-posterior fossa ovalis with a 71-cm 
Brockenbrough transseptal needle (BRK-1, St. Jude Medical, St. 
Paul, MN) and an 8.5-French 63-cm guiding introducer sheath 
(SL-1, St. Jude Medical), followed by an over-the-wire exchange for 
a 12-French steerable sheath (FlexCath Advance, Medtronic Inc., 
Minneapolis, MN). Unfractionated heparin was administered via 
intravenous boluses started prior to transseptal puncture, followed by 
a continuous infusion to achieve activated clotting times >300 seconds 
during ablation in the left atrium. Pulmonary vein isolation and 
superior vena cava isolation were performed under general anesthesia 
using a 28-mm cryoballoon ablation catheter (Arctic Front Advance, 
Medtronic Inc.) and a 4-mm radiofrequency ablation catheter (Blazer 
II, Boston Scientific, Natick, MA), respectively. Left atrial mapping 
and ablation were completed within 75 minutes exclusively with 
the cryoballoon sheath and catheter, and an additional 15 minutes 
were spent with the sheath and a radiofrequency ablation catheter in 
the right atrium to complete superior vena cava isolation. Heparin 
anticoagulation was then reversed with protamine, and six hours post 
procedure she was started on therapeutic oral anticoagulation with 
rivaroxban. She was discharged the next day in good condition.
On postoperative day#1, she developed a left occipital headache 
described as sharp but non-pulsatile that was initially mild in severity 
and relieved with oral acetaminophen. On post-operative day #3, the 
patient developed the sudden onset of visual symptoms described as 
bright flashes of light accompanied by blurriness of her peripheral 
vision bilaterally. Over the next 45 minutes, her vision normalized, 
at which time she developed recurrence of her left-sided headache. 
She had the return of similar visual symptoms the following day, and 
presented to the emergency department. Her blood pressure was 
113/73 with a pulse of 94 beats per minute. She was alert and oriented 
to time, person and place. Her neurologic examination was non-focal. 
Laboratory studies, including complete blood count, renal function, 
and serum electrolytes were all normal. Serum digoxin level was 
0.6 ng/mL. Electrocardiography and cardiac monitoring confirmed 
normal sinus rhythm. She underwent computed tomography (CT) 
imaging of her head, which showed no intracranial hemorrhage or 
mass lesion; CT angiography demonstrated no intracranial vascular 
stenosis. Magnetic resonance imaging of her brain was performed, 
which revealed only minimal nonspecific white matter disease, and 
no evidence of acute or subacute infarction [Figure 1]. Visualized 
portions of the orbits, optic nerves and visual pathways were also 
normal.
She was evaluated by the neurology service, who felt her 
presentation was consistent with a new onset migraine with visual 
aura. She had no previous history of migraine headaches. She did 
not have clinical evidence of an ischemic stroke or transient ischemic 
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Abstract
We report the case of a 58-year-old woman who developed a headache and visual disturbances after a cryoballoon ablation procedure for 
atrial fibrillation at our institution. She presented to the emergency department four days post ablation and was admitted the hospital for 
overnight observation. Serial neurological examinations and neuroimaging were unremarkable for stroke or transient ischemic attack. The 
patient had some brief transient visual changes which resolved completely after several days, with no further clinical sequelae. She followed 
up in the outpatient neuro-ophthalmology clinic and had a normal visual field examination. She was given a diagnosis of new onset migraine 
with visual aura.
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attack after overnight observation. She was discharged home in good 
condition. Over the next several days, she experienced some transient 
blurriness in her vision lasting approximately 45 minutes without 
headache or loss of peripheral vision. She had a follow-up visit in 
the neuro-ophthalmology clinic one week postoperatively, and both 
fundoscopic examination and visual field testing were within normal 
limits [Figure 2]. She had a follow-up visit in the cardiology clinic 
one month postoperatively, and described no further clinical sequelae.
Discussion
Catheter ablation of atrial fibrillation (AF) has evolved as a safe 
and highly effective treatment for drug-refractory symptomatic 
AF.[1]Over the last few years, cryoballoon ablation has become an 
increasingly utilized technique for the treatment of AF in the 
electrophysiology laboratory.[2] There have been a number of reports 
describing headache and migraines after AF ablation, including 
studies that suggest an increased incidence during and after 
cryoballoon AF ablation.[3]-[7]
There appears to be a specific link between the iatrogenic atrial septal 
defect (IASD) caused by transseptal puncture and the development 
of post-procedure migraines. In a series of 571 consecutive patients 
undergoing transseptal catheterization at the time of catheter ablation 
for left-sided cardiac arrhythmias at a single center, isolated migraine 
aura occurred with an incidence of about 0.5%. In these patients, 
transient and reversible visual symptoms were noted in the first week, 
with a negative workup for stroke or transient ischemic attack in all 
cases.[3] A larger series of 2,069 patients, undergoing radiofrequency 
catheter ablation for AF, saw a 2.3% incidence of post-procedure 
headaches, with new-onset definite migraines described in 1.1% of 
patients.[5] Another study did find an association between new or 
worsening migraine symptoms and silent cerebral infarcts on brain 
MRI after AF ablation, which suggest thromboembolism and/
or hypercoagulability may play a role in the development of post-
procedure migraines. [8] In fact, in this study, therapeutic levels of 
warfarin anticoagulation maintained during the peri-procedural 
period were associated with freedom from migraine. Specifically, it 
is hypothesized that IASD, similar to a native patent foramen ovale, 
can result in paradoxical embolism of platelets, thrombin and other 
substances that might contribute to the pathogenesis of migraine. [9]
Cryoballoon AF ablation is performed using a larger transseptal 
sheath (12 French inner diameter, as opposed to 8 or 8.5 French for 
radiofrequency AF ablation), which may be associated with a higher 
risk of persistent post-procedure IASD.[10] In a study of 87 consecutive 
patients followed for three months after cryoballoon ablation, 8% 
reported new symptoms of headache with ocular symptoms such 
as scotoma.[4] Most symptoms had disappeared when patients were 
reevaluated in the outpatient clinic three months after the ablation 
procedure. To the extent that the larger transseptal hole may allow 
for a greater propensity for thrombo-embolism and potentially 
migraine symptoms, anticoagulation strategies such as uninterrupted 
and therapeutic pre-procedure oral anticoagulation and intravenous 
heparinization prior to transseptal puncture, may be even more 
important for cryoballoon AF ablation than for radiofrequency AF 
ablation cases. Interestingly, in the study by Mohanty et al., there 
were no cases of new migraine or silent cerebral infarcts in the cohort 
that underwent AF ablation with therapeutic INR on the day of the 
ablation procedure. Pre-procedure warfarin was not utilized in our 
patient as she opted for an oral anticoagulant that would not require 
INR monitoring. It is common practice in our institution to suspend 
anticoagulation with a direct oral anticoagulant such as rivaroxaban 
24 to 48 hours pre-procedure, or initiate it postoperatively in patients 
who have not been previously anticoagulated. This practice is in 
contradistinction to the management of our patients on warfarin, 
which is not suspended pre-procedure, and may in retrospect have 
increased the risk of post-procedure migraine in this patient. Recent 
data on the use of direct oral anticoagulants during AF ablation 
suggest that uninterrupted apixaban administration may be a feasible 
and effective strategy in preventing thromboembolic events without 
increasing the risk of major bleeding complications. [11]
Figure 1:
Magnetic resonance imaging (MRI) of the brain obtained post 
ablation
Figure 2:
Visual field testing of left (left panel) and right (right panel) eyes 
post ablation
Conclusions
Migraine with visual aura is an increasingly recognized postoperative 
complication of AF catheter ablation procedures, and may be related 
to the presence and size of transseptal sheaths used intraoperatively, 
and the peri-procedural anticoagulant regimen. Neuroimaging 
and a thorough ophthalmologic examination are necessary to rule 
out potential thromboembolic and/or vascular causes in patients 
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